Mycobacterial mannose-capped lipoarabinomannan: a modulator bridging innate and adaptive immunity

References

• Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393:1642–1656. doi: 10.1016/S0140-6736(19)30308-3
   PubMed Web of Science ®Google Scholar
• Kallenius G, Correia-Neves M, Buteme H, et al. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations. Tuberculosis (Edinb). 2016;96:120–130. doi: 10.1016/j.tube.2015.09.005
   PubMed Web of Science ®Google Scholar
• Mishra AK, Driessen NN, Appelmelk BJ, et al. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev. 2011;35:1126–1157. doi: 10.1111/j.1574-6976.2011.00276.x
   PubMed Web of Science ®Google Scholar
• Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis. Biochimie. 2003;85:153–166. doi: 10.1016/S0300-9084(03)00048-8
   PubMed Web of Science ®Google Scholar
• Turner J, Torrelles JB. Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. Pathog Dis. 2018;76:fty026. doi: 10.1093/femspd/fty026
   PubMed Web of Science ®Google Scholar
• Schlesinger LS, Hull SR, Kaufman TM. Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol. 1994;152:4070–4079.
   PubMed Web of Science ®Google Scholar
• Maeda N, Nigou J, Herrmann JL, et al. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem. 2003;278:5513–5516. doi: 10.1074/jbc.C200586200
   PubMed Web of Science ®Google Scholar
• Ferguson JS, Voelker DR, McCormack FX, et al. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol. 1999;163:312–321.
   PubMed Web of Science ®Google Scholar
• Pan Q, Wang Q, Sun X, et al. Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys. Mol Ther. 2014;22:940–951. doi: 10.1038/mt.2014.31
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Sieling PA, Zhang N, et al. Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells. Glycobiology. 2012;22:1118–1127. doi: 10.1093/glycob/cws078
   PubMed Web of Science ®Google Scholar
• Zajonc DM, Ainge GD, Painter GF, et al. Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d. J Immunol. 2006;177:4577–4583. doi: 10.4049/jimmunol.177.7.4577
   PubMed Web of Science ®Google Scholar
• Gilleron M, Nigou J, Nicolle D, et al. The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem Biol. 2006;13:39–47. doi: 10.1016/j.chembiol.2005.10.013
   PubMed Web of Science ®Google Scholar
• Yuan C, Qu ZL, Tang XL, et al. Mycobacterium tuberculosis mannose-capped lipoarabinomannan induces IL-10-producing B cells and hinders CD4(+)Th1 immunity. iScience. 2019;11:13–30. doi: 10.1016/j.isci.2018.11.039
   PubMed Web of Science ®Google Scholar
• Toyonaga K, Torigoe S, Motomura Y, et al. C-Type lectin receptor DCAR recognizes mycobacterial phosphatidyl-inositol mannosides to promote a Th1 response during infection. Immunity. 2016;45(6):1245–1257. doi: 10.1016/j.immuni.2016.10.012
   PubMed Web of Science ®Google Scholar
• Hoppe HC, de Wet BJ, Cywes C, et al. Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells. Infect Immun. 1997;65:3896–3905.
   PubMed Web of Science ®Google Scholar
• Nakayama H, Kurihara H, Morita YS, et al. Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils. Sci Signal. 2016;9:ra101. doi: 10.1126/scisignal.aaf1585
   PubMed Web of Science ®Google Scholar
• Sidobre S, Nigou J, Puzo G, et al. Lipoglycans are putative ligands for the human pulmonary surfactant protein A attachment to mycobacteria. Critical role of the lipids for lectin-carbohydrate recognition. J Biol Chem. 2000;275:2415–2422. doi: 10.1074/jbc.275.4.2415
   PubMed Web of Science ®Google Scholar
• Yonekawa A, Saijo S, Hoshino Y, et al. Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria. Immunity. 2014;41:402–413. doi: 10.1016/j.immuni.2014.08.005
   PubMed Web of Science ®Google Scholar
• Sun X, Pan Q, Yuan C, et al. A single ssDNA aptamer binding to mannose-capped lipoarabinomannan of Bacillus Calmette-Guerin enhances immunoprotective effect against tuberculosis. J Am Chem Soc. 2016;138:11680–11689. doi: 10.1021/jacs.6b05357
   PubMed Web of Science ®Google Scholar
• Tang XL, Yuan CH, Ding Q, et al. Selection and identification of specific glycoproteins and glycan biomarkers of macrophages involved in Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2017;104:95–106. doi: 10.1016/j.tube.2017.03.010
   PubMed Web of Science ®Google Scholar
• Decout A, Silva-Gomes S, Drocourt D, et al. Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2. Sci Rep. 2018;8:16840. doi: 10.1038/s41598-018-35393-5
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Azad AK, Schlesinger LS. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J Immunol. 2006;177:1805–1816. doi: 10.4049/jimmunol.177.3.1805
   PubMed Web of Science ®Google Scholar
• Geijtenbeek TB, Van Vliet SJ, Koppel EA, et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med. 2003;197:7–17. doi: 10.1084/jem.20021229
   PubMed Web of Science ®Google Scholar
• Gazi U, Martinez-Pomares L. Influence of the mannose receptor in host immune responses. Immunobiology. 2009;214:554–561. doi: 10.1016/j.imbio.2008.11.004
   PubMed Web of Science ®Google Scholar
• Rajaram MV, Brooks MN, Morris JD, et al. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol. 2010;185:929–942. doi: 10.4049/jimmunol.1000866
   PubMed Web of Science ®Google Scholar
• Pan Q, Yan J, Liu Q, et al. A single-stranded DNA aptamer against mannose-capped lipoarabinomannan enhances anti-tuberculosis activity of macrophages through downregulation of lipid-sensing nuclear receptor peroxisome proliferator-activated receptor gamma expression. Microbiol Immunol. 2017;61:92–102. doi: 10.1111/1348-0421.12470
   PubMed Web of Science ®Google Scholar
• Halder P, Kumar R, Jana K, et al. Gene expression profiling of Mycobacterium tuberculosis Lipoarabinomannan-treated macrophages: A role of the Bcl-2 family member A1 in inhibition of apoptosis in mycobacteria-infected macrophages. IUBMB Life. 2015;67:726–736. doi: 10.1002/iub.1430
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhao GW, Gao CH, et al. Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces IL-37 production via upregulating ERK1/2 and p38 in human type II alveolar epithelial cells. Int J Clin Exp Med. 2015;8:7279–7287.
   PubMed Web of Science ®Google Scholar
• Piermattei A, Migliara G, Di Sante G, et al. Toll-like receptor 2 mediates in vivo pro- and anti-inflammatory effects of Mycobacterium Tuberculosis and modulates autoimmune encephalomyelitis. Front Immunol. 2016;7:191. doi: 10.3389/fimmu.2016.00191
   PubMed Web of Science ®Google Scholar
• Khan A, Singh VK, Hunter RL, et al. Macrophage heterogeneity and plasticity in tuberculosis. J Leukoc Biol. 2019. DOI:10.1002/JLB.MR0318-095RR.
   Web of Science ®Google Scholar
• Lundahl MLE, Scanlan EM, Lavelle EC. Therapeutic potential of carbohydrates as regulators of macrophage activation. Biochem Pharmacol. 2017;146:23–41. doi: 10.1016/j.bcp.2017.09.003
   PubMed Web of Science ®Google Scholar
• Marshall BG, Wangoo A, Harrison LI, et al. Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid. Eur Respir J. 2000;15:764–770. doi: 10.1034/j.1399-3003.2000.15d22.x
   PubMed Web of Science ®Google Scholar
• Sibley LD, Hunter SW, Brennan PJ, et al. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun. 1988;56:1232–1236.
   PubMed Web of Science ®Google Scholar
• Sibley LD, Adams LB, Krahenbuhl JL. Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan. Clin Exp Immunol. 1990;80:141–148. doi: 10.1111/j.1365-2249.1990.tb06454.x
   PubMed Web of Science ®Google Scholar
• Kang PB, Azad AK, Torrelles JB, et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med. 2005;202:987–999. doi: 10.1084/jem.20051239
   PubMed Web of Science ®Google Scholar
• Ullrich HJ, Beatty WL, Russell DG. Interaction of Mycobacterium avium-containing phagosomes with the antigen presentation pathway. J Immunol. 2000;165:6073–6080. doi: 10.4049/jimmunol.165.11.6073
   PubMed Web of Science ®Google Scholar
• Welin A, Winberg ME, Abdalla H, et al. Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun. 2008;76:2882–2887. doi: 10.1128/IAI.01549-07
   PubMed Web of Science ®Google Scholar
• Vergne I, Chua J, Deretic V. Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3 K hVPS34 cascade. J Exp Med. 2003;198:653–659. doi: 10.1084/jem.20030527
   PubMed Web of Science ®Google Scholar
• Fratti RA, Backer JM, Gruenberg J, et al. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol. 2001;154:631–644. doi: 10.1083/jcb.200106049
   PubMed Web of Science ®Google Scholar
• Mazurek J, Ignatowicz L, Kallenius G, et al. Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells. PLoS One. 2012;7:e42515. doi: 10.1371/journal.pone.0042515
   PubMed Web of Science ®Google Scholar
• Dulphy N, Herrmann JL, Nigou J, et al. Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells. Cell Microbiol. 2007;9:1412–1425. doi: 10.1111/j.1462-5822.2006.00881.x
   PubMed Web of Science ®Google Scholar
• Wu T, Guo S, Wang J, et al. Interaction between mannosylated lipoarabinomannan and dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin influences dendritic cells maturation and T cell immunity. Cell Immunol. 2011;272:94–101. doi: 10.1016/j.cellimm.2011.09.001
   PubMed Web of Science ®Google Scholar
• Faldt J, Dahlgren C, Ridell M, et al. Priming of human neutrophils by mycobacterial lipoarabinomannans: role of granule mobilisation. Microbes Infect. 2001;3:1101–1109. doi: 10.1016/S1286-4579(01)01470-8
   PubMed Web of Science ®Google Scholar
• Blattes E, Vercellone A, Eutamene H, et al. Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment. Proc Natl Acad Sci USA. 2013;110:8795–8800. doi: 10.1073/pnas.1221708110
   PubMed Web of Science ®Google Scholar
• Moody DB, Zajonc DM, Wilson IA. Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol. 2005;5:387–399. doi: 10.1038/nri1605
   PubMed Web of Science ®Google Scholar
• Sada-Ovalle I, Chiba A, Gonzales A, et al. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog. 2008;4:e1000239. doi: 10.1371/journal.ppat.1000239
   PubMed Web of Science ®Google Scholar
• Venkataswamy MM, Baena A, Goldberg MF, et al. Incorporation of NKT cell-activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J Immunol. 2009;183:1644–1656. doi: 10.4049/jimmunol.0900858
   PubMed Web of Science ®Google Scholar
• Shimamura M. Non-reducing end alpha-mannosylated glycolipids as potent activators for invariant Valpha19 TCR-bearing natural killer T cells. Carbohydr Res. 2008;343:2010–2017. doi: 10.1016/j.carres.2008.04.001
   PubMed Web of Science ®Google Scholar
• Prigozy TI, Sieling PA, Clemens D, et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 1997;6:187–197. doi: 10.1016/S1074-7613(00)80425-2
   PubMed Web of Science ®Google Scholar
• Mahon RN, Sande OJ, Rojas RE, et al. Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation. Cell Immunol. 2012;275:98–105. doi: 10.1016/j.cellimm.2012.02.009
   PubMed Web of Science ®Google Scholar
• Torrelles JB, Khoo KH, Sieling PA, et al. Truncated structural variants of lipoarabinomannan in Mycobacterium leprae and an ethambutol-resistant strain of Mycobacterium tuberculosis. J Biol Chem. 2004;279:41227–44139. doi: 10.1074/jbc.M405180200
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Visvabharathy L, Wang CR. Role of Group 1 CD1-Restricted T Cells in Infectious Disease. Front Immunol. 2015;6:337. doi: 10.3389/fimmu.2015.00337
   PubMed Web of Science ®Google Scholar
• Ulrichs T, Moody DB, Grant E, et al. T-cell responses to CD1-presented lipid antigens in humans with Mycobacterium tuberculosis infection. Infect Immun. 2003;71:3076–3087. doi: 10.1128/IAI.71.6.3076-3087.2003
   PubMed Web of Science ®Google Scholar
• Busch M, Herzmann C, Kallert S, et al. Lipoarabinomannan-responsive polycytotoxic t cells are associated with protection in human tuberculosis. Am J Respir Crit Care Med. 2016;194:345–355. doi: 10.1164/rccm.201509-1746OC
   PubMed Web of Science ®Google Scholar
• Sande OJ, Karim AF, Li Q, et al. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL. J Immunol. 2016;196:691–702. doi: 10.4049/jimmunol.1500710
   PubMed Web of Science ®Google Scholar
• Karim AF, Sande OJ, Tomechko SE, et al. Proteomics and network analyses reveal inhibition of Akt-mTOR Signaling in CD4(+) T Cells by Mycobacterium tuberculosis mannose-capped lipoarabinomannan. Proteomics. 2017;17:1700233. doi: 10.1002/pmic.201700233
   PubMed Web of Science ®Google Scholar
• Garg A, Barnes PF, Roy S, et al. Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection. Eur J Immunol. 2008;38:459–469. doi: 10.1002/eji.200737268
   PubMed Web of Science ®Google Scholar
• Periasamy S, Dhiman R, Barnes PF, et al. Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation With Mycobacterium tuberculosis. J Infect Dis. 2011;203:1256–1263. doi: 10.1093/infdis/jir011
   PubMed Web of Science ®Google Scholar
• Richmond JM, Lee J, Green DS, et al. Mannose-capped lipoarabinomannan from Mycobacterium tuberculosis preferentially inhibits sphingosine-1-phosphate-induced migration of Th1 cells. J Immunol. 2012;189:5886–5895. doi: 10.4049/jimmunol.1103092
   PubMed Web of Science ®Google Scholar
• Shabaana AK, Kulangara K, Semac I, et al. Mycobacterial lipoarabinomannans modulate cytokine production in human T helper cells by interfering with raft/microdomain signalling. Cell Mol Life Sci. 2005;62:179–187. doi: 10.1007/s00018-004-4404-5
   PubMed Web of Science ®Google Scholar
• Misaki A, Azuma I, Yamamura Y. Structural and immunochemical studies on D-arabino-D-mannans and D-mannans of Mycobacterium tuberculosis and other Mycobacterium species. J Biochem. 1977;82:1759–1770. doi: 10.1093/oxfordjournals.jbchem.a131874
   PubMed Web of Science ®Google Scholar
• Gaylord H, Brennan PJ, Young DB, et al. Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun. 1987;55:2860–2863.
   PubMed Web of Science ®Google Scholar
• Hunter SW, Gaylord H, Brennan PJ. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem. 1986;261:12345–12351.
   PubMed Web of Science ®Google Scholar
• Rademacher C, Shoemaker GK, Kim HS, et al. Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside-protein recognition. J Am Chem Soc. 2007;129:10489–104502. doi: 10.1021/ja0723380
   PubMed Web of Science ®Google Scholar
• Kaur D, Lowary TL, Vissa VD, et al. Characterization of the epitope of anti-lipoarabinomannan antibodies as the terminal hexaarabinofuranosyl motif of mycobacterial arabinans. Microbiology. 2002;148(Pt 10):3049–3057. doi: 10.1099/00221287-148-10-3049
   PubMed Web of Science ®Google Scholar
• de Valliere S, Abate G, Blazevic A, et al. Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies. Infect Immun. 2005;73:6711–6720. doi: 10.1128/IAI.73.10.6711-6720.2005
   PubMed Web of Science ®Google Scholar
• Hamasur B, Haile M, Pawlowski A, et al. A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab’) fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol. 2004;138:30–38. doi: 10.1111/j.1365-2249.2004.02593.x
   PubMed Web of Science ®Google Scholar
• Costello AM, Kumar A, Narayan V, et al. Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans R Soc Trop Med Hyg. 1992;86:686–692. doi: 10.1016/0035-9203(92)90192-F
   PubMed Web of Science ®Google Scholar
• Perley CC, Frahm M, Click EM, et al. The human antibody response to the surface of Mycobacterium tuberculosis. PLoS One. 2014;9:e98938. doi: 10.1371/journal.pone.0098938
   PubMed Web of Science ®Google Scholar
• Kumar SK, Singh P, Sinha S. Naturally produced opsonizing antibodies restrict the survival of Mycobacterium tuberculosis in human macrophages by augmenting phagosome maturation. Open Biol. 2015;5:150171. doi: 10.1098/rsob.150171
   PubMed Web of Science ®Google Scholar
• Choudhary A, Patel D, Honnen W, et al. Characterization of the antigenic heterogeneity of lipoarabinomannan, the major surface glycolipid of Mycobacterium tuberculosis, and complexity of antibody specificities toward this antigen. J Immunol. 2018;200:3053–3066. doi: 10.4049/jimmunol.1701673
   PubMed Web of Science ®Google Scholar
• Chattree V, Khanna N, Bisht V, et al. Inhibition of apoptosis, activation of NKT cell and upregulation of CD40 and CD40L mediated by M. leprae antigen(s) combined with Murabutide and Trat peptide in leprosy patients. Mol Cell Biochem. 2008;309:87–97. doi: 10.1007/s11010-007-9646-8
   PubMed Web of Science ®Google Scholar
• Paris L, Magni R, Zaidi F, et al. Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity. Sci Transl Med. 2017;9:eaal2807. doi: 10.1126/scitranslmed.aal2807
   PubMed Web of Science ®Google Scholar
• Crawford AC, Laurentius LB, Mulvihill TS, et al. Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering. Analyst. 2016;142:186–196. doi: 10.1039/C6AN02110G
   PubMed Web of Science ®Google Scholar
• Tang XL, Wu SM, Xie Y, et al. Generation and application of ssDNA aptamers against glycolipid antigen ManLAM of Mycobacterium tuberculosis for TB diagnosis. J Infect. 2016;72:573–586. doi: 10.1016/j.jinf.2016.01.014
   PubMed Web of Science ®Google Scholar
• Afonso-Barroso A, Clark SO, Williams A, et al. Lipoarabinomannan mannose caps do not affect mycobacterial virulence or the induction of protective immunity in experimental animal models of infection and have minimal impact on in vitro inflammatory responses. Cell Microbiol. 2013;15:660–674. doi: 10.1111/cmi.12065
   PubMed Web of Science ®Google Scholar
• Stoop EJ, Mishra AK, Driessen NN, et al. Mannan core branching of lipo(arabino)mannan is required for mycobacterial virulence in the context of innate immunity. Cell Microbiol. 2013;15:2093–2108. doi: 10.1111/cmi.12175
   PubMed Web of Science ®Google Scholar
• Quesniaux VJ, Nicolle DM, Torres D, et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol. 2004;172:4425–4434. doi: 10.4049/jimmunol.172.7.4425
   PubMed Web of Science ®Google Scholar
• Doz E, Rose S, Nigou J, et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J Biol Chem. 2007;282:26014–22625. doi: 10.1074/jbc.M702690200
   PubMed Web of Science ®Google Scholar